MetLife Valuation

Is MET undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MET when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MET ($86.59) is trading below our estimate of fair value ($128.16)

Significantly Below Fair Value: MET is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MET?

Key metric: As MET is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MET. This is calculated by dividing MET's market cap by their current earnings.
What is MET's PE Ratio?
PE Ratio16.8x
EarningsUS$3.56b
Market CapUS$59.96b

Price to Earnings Ratio vs Peers

How does MET's PE Ratio compare to its peers?

The above table shows the PE ratio for MET vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average12.5x
AFL Aflac
16.4x-1.7%US$62.4b
PRU Prudential Financial
11.2x6.8%US$45.5b
UNM Unum Group
7.9x-3.9%US$13.8b
PRI Primerica
14.6x6.8%US$10.1b
MET MetLife
16.8x13.2%US$60.0b

Price-To-Earnings vs Peers: MET is expensive based on its Price-To-Earnings Ratio (16.8x) compared to the peer average (12.5x).


Price to Earnings Ratio vs Industry

How does MET's PE Ratio compare vs other companies in the US Insurance Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
2xn/aUS$89.08m
AORE.F American Overseas Group
2.1xn/aUS$16.68m
CUII China United Insurance Service
0.0003xn/aUS$3.13k
No more companies available in this PE range
MET 16.8xIndustry Avg. 13.7xNo. of Companies15PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MET is expensive based on its Price-To-Earnings Ratio (16.8x) compared to the US Insurance industry average (13.7x).


Price to Earnings Ratio vs Fair Ratio

What is MET's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MET PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.8x
Fair PE Ratio17.1x

Price-To-Earnings vs Fair Ratio: MET is good value based on its Price-To-Earnings Ratio (16.8x) compared to the estimated Fair Price-To-Earnings Ratio (17.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MET forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$86.59
US$91.46
+5.6%
9.5%US$101.00US$68.00n/a13
Nov ’25US$78.43
US$89.23
+13.8%
8.6%US$98.00US$68.00n/a13
Oct ’25US$81.78
US$85.77
+4.9%
7.8%US$96.00US$68.00n/a13
Sep ’25US$77.48
US$83.83
+8.2%
7.2%US$96.00US$68.00n/a12
Aug ’25US$75.78
US$83.49
+10.2%
8.6%US$96.00US$66.00n/a13
Jul ’25US$69.88
US$82.03
+17.4%
8.9%US$99.00US$66.00n/a13
Jun ’25US$72.37
US$82.41
+13.9%
9.1%US$99.00US$66.00n/a13
May ’25US$71.88
US$82.31
+14.5%
10.8%US$104.00US$66.00n/a14
Apr ’25US$73.69
US$79.52
+7.9%
8.0%US$88.00US$66.00n/a14
Mar ’25US$69.73
US$79.52
+14.0%
8.0%US$88.00US$66.00n/a14
Feb ’25US$65.35
US$78.81
+20.6%
8.4%US$88.00US$63.00n/a15
Jan ’25US$66.13
US$77.21
+16.8%
7.9%US$86.00US$63.00n/a15
Dec ’24US$63.76
US$76.36
+19.8%
8.6%US$86.00US$63.00n/a15
Nov ’24US$59.98
US$76.74
+27.9%
8.6%US$85.00US$63.00US$78.4314
Oct ’24US$62.91
US$77.10
+22.6%
8.7%US$85.00US$63.00US$81.7814
Sep ’24US$64.30
US$76.10
+18.4%
10.9%US$85.00US$58.00US$77.4814
Aug ’24US$62.82
US$74.54
+18.7%
11.6%US$85.00US$58.00US$75.7814
Jul ’24US$56.53
US$73.86
+30.7%
10.7%US$85.00US$58.00US$69.8814
Jun ’24US$50.38
US$75.21
+49.3%
11.4%US$86.00US$60.00US$72.3714
May ’24US$61.26
US$76.00
+24.1%
10.1%US$86.00US$60.00US$71.8816
Apr ’24US$57.94
US$79.88
+37.9%
10.1%US$90.00US$60.00US$73.6916
Mar ’24US$71.27
US$81.94
+15.0%
7.2%US$90.00US$63.00US$69.7316
Feb ’24US$72.68
US$82.13
+13.0%
7.6%US$93.00US$63.00US$65.3516
Jan ’24US$72.37
US$80.73
+11.6%
6.8%US$87.00US$63.00US$66.1315
Dec ’23US$76.65
US$81.00
+5.7%
7.0%US$87.00US$63.00US$63.7615
Nov ’23US$73.94
US$76.81
+3.9%
5.9%US$83.00US$63.00US$59.9816

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies